Santarus, Inc. (NASDAQ:SNTS) Investor Alert: Investigation of Takeover at $32 by Salix Pharmaceuticals
An investigation on behalf of investors, who currently hold shares of Santarus, Inc. (NASDAQ:SNTS) shares, was announced concerning whether the takeover of Santarus, Inc. by Salix Pharmaceuticals, Ltd for $32.00 per share is unfair to NASDAQ:SNTS stockholders.
View full press release